Moderna (MRNA) Change in Inventory (2020 - 2026)

Moderna (MRNA) has 7 years of Change in Inventory data on file, last reported at -$6.0 million in Q1 2026.

• On a quarterly basis, Change in Inventory fell 175.0% year-over-year to -$6.0 million in Q1 2026; TTM through Mar 2026 was $20.0 million, a 111.9% increase from a year earlier, with the FY2025 full-year figure at $34.0 million, up 140.96% from the prior year.
• Change in Inventory for Q1 2026 stood at -$6.0 million, up from -$179.0 million in the prior quarter.
• Over the last five years, Change in Inventory for MRNA reached as high as $501.0 million in Q1 2022 and fell as low as -$1.1 billion in Q4 2022.
• Historically, Change in Inventory has averaged -$76.1 million across 5 years, with a median of -$6.0 million in 2026.
• Across the five-year window, Change in Inventory tumbled 336.97% in 2022 and jumped 727.27% in 2025, its largest moves.
• Year by year, Change in Inventory stood at -$1.1 billion in 2022, then jumped by 74.73% to -$285.0 million in 2023, then decreased by 2.11% to -$291.0 million in 2024, then jumped by 38.49% to -$179.0 million in 2025, then soared by 96.65% to -$6.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were -$6.0 million in Q1 2026, -$179.0 million in Q4 2025, and $91.0 million in Q3 2025.